2016
- What is the optimal dosing of 4-factor prothrombin complex concentrate in patients with warfarin-associated bleeding?
- Is there updated information on the off-label use of dexmedetomidine (Precedex®) for alcohol withdrawal syndrome?
- What is the available evidence for the use of sodium thiosulfate for non-uremic calciphylaxis?
- What drugs can be used to manage floppy iris syndrome during cataract surgery?
- What is the latest information on gadolinium-based contrast agents and brain deposits?
- Is there literature to support the adjunct use of simethicone prior to colonoscopy to improve visualization?
- What are the data on efficacy and safety of using injectable tobramycin for inhalation via nebulization?
- What are the comparative clinical data for albuterol versus levalbuterol?
- What evidence supports the efficacy of ranolazine (Ranexa®) for the treatment of atrial fibrillation?
- Dexrazoxane and the risk secondary cancer in pediatric patients: Can this controversy be laid to rest?
- What are alternatives to sublingually administered ophthalmic atropine for treatment of noisy breathing in terminally ill patients?
- How should medications be appropriately managed following bariatric surgery?
- What evidence supports the use of antibiotic-loaded bone cement to prevent infection in primary hip and knee arthroplasty?
- What does the American Psychiatric Association recommend regarding the use of antipsychotics in patients with dementia?
- Can a simplified 2-bag acetylcysteine approach improve tolerability in acetaminophen overdoses?
- What evidence is available for the use of fluorescein for gastrointestinal and genitourinary procedures?
- What is the evidence to support the new 2016 heart failure update and place in therapy of the new heart failure agents?
- What is the comparative evidence on use of IV acetaminophen versus oral acetaminophen?
- What evidence is available for efficacy and stability of high dose mitomycin C concentrations?
- What evidence supports or refutes the use of medical grade honey for wound healing?
- What are the new 2016 ACC/AHA guideline recommendations for dual antiplatelet therapy?
- What are the key changes to drug therapy recommendations in the 2016 AACE type 2 diabetes algorithm?
- What are the clinical implications of the 2016 American Epilepsy Society (AES) guidelines for status epilepticus?
- What is the clinical evidence for the use of sugammadex (Bridion®)?
- What are the 2016 guideline recommendations for the management of postoperative pain?
- What is the most recent evidence for using probiotics in patients with Clostridium difficile?
- Does adjunctive corticosteroid therapy improve outcomes in patients with community-acquired pneumonia?
- What data support selexipag and initial ambrisentan/tadalafil therapy for pulmonary arterial hypertension?
- What information is available on Zika virus infection?
- What are the major drug-related changes to the 2016 update of the CHEST Guideline for Antithrombotic Therapy for VTE Disease?
- Do the insulin glargine products Basaglar and Lantus have similar safety and efficacy profiles?
- Should blood pressure goals be lowered based on recent evidence?
- Are proton pump inhibitors (PPIs) associated with negative outcomes in patients with cirrhosis?
- What data are available comparing liposomal bupivacaine to other agents?
- Can estimated patient weight be safely used for dosing of alteplase for acute ischemic stroke?
- What are the key features of the new rheumatoid arthritis guidelines?